Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2017 · 10-Q
Revenue$110.16M$110.16M−21.6% vs Q2 2016 Net Income$1.33M$1.33M−29.0% vs Q2 2016 EPS Diluted$0.05$0.05−28.6% vs Q2 2016 Gross Profit$17,103,000−0.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$9,712,000+140.0% Free Cash Flowderived-$7,049,000N/M Margins · derivedGross margin15.5%+3.2 pt vs Q2 2016
Operating margin3.0%+1.0 pt vs Q2 2016
Net margin1.2%−0.1 pt vs Q2 2016
ended Nov 27, 2016 · filed Jan 5, 2017 · 39 d after period end